Xconomy National

Archives

by in

Entry	Author	Date	Location
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News	Luke Timmerman	03/10/11	Seattle
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London	Luke Timmerman	03/09/11	Seattle
Burrill’s Bet on Seattle, Yamada Exits Gates Foundation, Stewart Parker’s New Gig, & More Seattle-Area Life Sciences News	Luke Timmerman	02/17/11	Seattle
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort	Luke Timmerman	02/15/11	Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News	Luke Timmerman	11/18/10	Seattle
Targeted Genetics Seeks Merger	Luke Timmerman	11/12/10	Seattle
Seattle Children’s Moves in at Prominent Biotech Address as Targeted Genetics Moves Out	Luke Timmerman	08/18/10	Seattle
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study	Luke Timmerman	06/01/10	San Diego
H. Stewart Parker Joins WBBA	Luke Timmerman	04/28/10	Seattle
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details	Luke Timmerman	04/28/10	San Diego
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News	Luke Timmerman	04/22/10	Seattle
Targeted Genetics Cuts 3 Directors	Luke Timmerman	04/16/10	Seattle
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News	Luke Timmerman	03/25/10	Seattle
OncoGenex Adds New Chairman	Luke Timmerman	03/24/10	Seattle
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News	Luke Timmerman	01/14/10	Seattle
Targeted Genetics Exits Nasdaq	Luke Timmerman	01/13/10	Seattle
A Brief Year-End Review of Seattle Biotech	Stewart Lyman	12/31/09	Seattle
Dendreon Nails Down $409M, Stewart Parker Gets Itch to Return, Seattle Genetics Finds New Partner, & More Seattle-Area Life Sciences News	Luke Timmerman	12/17/09	Seattle
From Russia With Love (for Biotech), Stewart Parker Gets “Antsy” to Return	Luke Timmerman	12/14/09	Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009	Luke Timmerman	09/22/09	Seattle
Celladon, Developer of Gene Therapy for Heart Failure, Secures Part of $24.6M Venture Round	Luke Timmerman	09/15/09	San Diego
Arena Prepares to Release Big Obesity Study, Minnow Medical Goes Into ‘Commercialization Mode,’ Metabasis Hires Strategic Adviser, & More San Diego Life Sciences News	Bruce V. Bigelow	09/10/09	San Diego
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News	Luke Timmerman	09/10/09	Seattle
Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M	Luke Timmerman	09/09/09	National
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News	Luke Timmerman	08/27/09	Seattle
Biotechs Go Back to the Future by Re-Innovating Old Drugs	Denise Gellene	08/26/09	San Diego
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies	Luke Timmerman	08/25/09	Seattle
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News	Luke Timmerman	08/13/09	Seattle
Targeted ‘Must Raise’ Cash	Luke Timmerman	08/12/09	Seattle
Seattle Layoff Update: Targeted Genetics, Wetpaint, Google, and Others Cut Staff	Gregory T. Huang	07/27/09	Seattle
Page 1 of 3	next page »